Literature DB >> 6488489

Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.

A Schömig, A M Dart, R Dietz, E Mayer, W Kübler.   

Abstract

The accumulation of endogenous catecholamines within the extracellular space of the ischemic myocardium has been studied in the isolated perfused (Langendorff) heart of the rat subjected to various periods of complete ischemia, with subsequent collection of the reperfusate. Catecholamines and deaminated metabolites were measured by radioenzymatic methods, or high pressure liquid chromatography. Ischemic periods of less than 10 minutes are not associated with an increased overflow of catecholamines or metabolites. Longer periods of ischemia are accompanied by the overflow of noradrenaline and its deaminated metabolite 3,4-dihydroxyphenylglycol. This overflow increases with lengthening of the preceding ischemic period (10 minutes: 2.5 +/- 0.6, 20 minutes: 209.8 +/- 17.2, 60 minutes: 1270.5 +/- 148.1 pmol noradrenaline/g heart). Noradrenaline concentration is highest during the first minute of reperfusion, suggesting that the noradrenaline detected during reperfusion is released into the extracellular space of the myocardium during ischemia and is subsequently eluted. Experiments with variation of extracellular calcium concentration and with neuronal uptake (uptake1) blocking agents suggest that different mechanisms of catecholamine release are acting during the course of ischemia. A calcium-independent carrier-mediated efflux of noradrenaline from the nerve terminals is of major importance, using the same carrier as is normally responsible for transporting noradrenaline from the synaptic clefts into the neuronal varicosities. Thus, various uptake1-blocking agents diminish the noradrenaline overflow following ischemic periods of between 10 and 40 minutes. The noradrenaline overflow following longer periods of ischemia is unaffected by uptake1-blocking agents, and additional noradrenaline release at this time is probably consequent upon dissolution of cell membranes. Overflow of adrenaline and dopamine occurs to a minor degree (less than 5% of the corresponding noradrenaline overflow), and only after ischemic periods of more than 15 minutes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488489     DOI: 10.1161/01.res.55.5.689

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  65 in total

1.  Massive atrial natriuretic peptide (ANP) release in ischemia reperfusion.

Authors:  A Lochner; S Genade; R Mouton
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

2.  A microdialysis investigation of the release of norepinephrine in the hypothalamus induced by 2-deoxyglucose in awake rats.

Authors:  A I Kuz'min; M B Bogdanov; O S Medvedev
Journal:  Neurosci Behav Physiol       Date:  1992 Sep-Oct

3.  Occurrence and prevention of contraction bands in Purkinje fibres, transitional cells and working myocardium during global ischaemia.

Authors:  P A Schnabel; A Schmiedl; B Ramsauer; U Bartels; M M Gebhard; J Richter; H J Bretschneider
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Release of noradrenaline from isolated rat tail artery induced by bafilomycin A1.

Authors:  V Palatý
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

5.  Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.

Authors:  V Richard; B Ghaleh; A Berdeaux; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Slowing of shortening velocity of rat cardiac myocytes by adenosine receptor stimulation regardless of beta-adrenergic stimulation.

Authors:  K T Strang; R M Mentzer; R L Moss
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

7.  Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.

Authors:  M Kitakaze; M Hori; T Morioka; T Minamino; S Takashima; H Sato; Y Shinozaki; M Chujo; H Mori; M Inoue
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Dual effect of nicotine on cardiac noradrenaline release during metabolic blockade.

Authors:  G Richardt; T Brenn; M Seyfarth; M Haass; E Schömig; A Schömig
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

9.  Antiarrhythmic and antinecrotic effects of yohimbine stereoisomers in rats during coronary occlusion and reperfusion.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

10.  Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia/reperfusion and hypoxia/reoxygenation in rats.

Authors:  S Takeo; Y Nasa; K Tanonaka; K Yabe; M Nojiri; M Hayashi; H Sasaki; K Ida; K Yanai
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.